In a recent study, cardiovascular disease events were seen more often in women with irregular or long or short menstrual cycles.

Medical care, lost productivity, premature deaths take a huge toll on patients, families, and the economy, according to researchers.

In this video interview, experts provide a synopsis of their presentation about technology and obstetric care at the 2023 ACOG Annual Clinical and Scientific Meeting.

In a recent study, increased street view-based green space, especially tree coverage, led to decreased risks of depression in post partum women, with mediation effects observed for physical activity.

In a recent study, use of β3-adrenoceptor agonists over anticholinergic prescriptions differed based on patient race.

New data indicates that increased risk for offspring in developing different disorders is associated with maternal alopecia areata exposure, expanding the available information on alopecia and maternal autoimmunity.

In a recent study, midlife women with prediabetes before menopause transition were more likely to experience fractures in postmenopause.

In a recent study, pregnant people receiving extracorporeal membrane oxygenation experienced low mortality rates but high morbidity rates.

New data indicates the usefulness of spironolactone as an alternative to oral antibiotics for women in the UK with acne vulgaris, given increasing resistance to antibiotics due to widespread use.

In a recent study, induction of labor was found safe and beneficial in pregnant women at 39 weeks of gestation, with increased risks only seen for shoulder dystocia in nulliparous women.

Many barriers lead to low rates of use of LARCs.

Physicians debate merits of face covers as virus becomes endemic in the population.

In a recent study, mental disorders were more commonly seen in offspring of mothers diagnosed with 1 or more autoimmune diseases before or during pregnancy.

At the 2023 ACOG Annual Clinical and Scientific Meeting, Haywood Brown, MD, discusses the current maternal mortality rate in the United States, as well as disparities affecting different racial and ethnic groups.

At the 2023 ACOG Annual Clinical & Scientific Meeting, Caitlin Martin, MD, discussed the concerning rise in substance use mortalities and maternal mortalities.

At the 2023 ACOG Annual Clinical & Scientific Meeting, the efficacy and satisfaction rates of pessaries in patients with prolapse symptoms were discussed.

At the 2023 ACOG Annual Clinical & Scientific Meeting, a study on whether telemedicine contributes to patient adherence and satisfaction for gynecologic visits.

Anne Banfield, MD, discusses the highlights from her presentation on primary HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland.

At the 2023 ACOG Annual Clinical & Scientific Meeting, a look at how AI and immunofluorescence scanning microscopy can help in detecting vaginitis and increase the health of the vaginal microbiome.

At the 2023 ACOG Annual Clinical & Scientific Meeting, methods of providing contraception to adolescents in a post-Dobbs era were discussed.

At the 2023 ACOG Annual Clinical & Scientific Meeting, the safety and efficacy of compounded bioidentical hormone therapy for menopause were discussed.

At the 2023 ACOG Annual Clinical & Scientific Meeting, Gloria Richard-Davis MD, MBA, NCMP, FACOG, discussed the importance of using hormone therapies to treat menopause symptoms.

At the 2023 ACOG Annual Clinical & Scientific Meeting, methods of reducing disparities in vaccinations among pregnant and postpartum people were discussed.

Genevieve Neal-Perry, MD, PhD, talks about the recent approval of fezolinetant (Veozah; Astellas Pharma) and her latest phase 3 research presented at the 2023 ACOG Annual Clinical and Scientific Meeting.